Jasuja, Guneet K. Bhasin, Shalender Reisman, Joel I. Hanlon, Joseph T. Miller, Donald R. Morreale, Anthony P. Pogach, Leonard M. Cunningham, Francesca E. Park, Angela Berlowitz, Dan R. and Rose, Adam J. 2017. Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: a Cross-Sectional Study. Journal of General Internal Medicine, Vol. 32, Issue. 3, p. 304.
Fakhari, Ali Farahbakhsh, Mostafa Aboulghasemi fakhri, Narges and Minashiri, Abdolkhalegh 2015. Investigation of the difference between the expression and presence of sexual symptoms and dysfunction in depressed women treated with fluoxetine. Journal of Analytical Research in Clinical Medicine, Vol. 3, Issue. 4, p. 244.
Hamilton, Ian Pringle, Rose and Hemingway, Stephen 2015. Psychotropic induced sexual dysfunction for people with a dual diagnosis. Advances in Dual Diagnosis, Vol. 8, Issue. 4, p. 167.
Ward, Rosalind F and Manchip, Simon 2013. ‘Inappropriate’ sexual behaviours in dementia. Reviews in Clinical Gerontology, Vol. 23, Issue. 01, p. 75.
Wylie, K.R. Wood, A. and McManus, R. 2013. Sexuality and old age. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, Vol. 56, Issue. 2, p. 223.
Sidi, Hatta Asmidar, Duni Hod, Rozita and Guan, Ng Chong 2012. Female Sexual Dysfunction in Patients Treated with Antidepressant—Comparison between Escitalopram and Fluoxetine. The Journal of Sexual Medicine, Vol. 9, Issue. 5, p. 1392.
Al-Khaja, Khalid A. J. Sequeira, Reginald P. Al-Haddad, Mohammed K. and Al-Offi, Adel R. 2012. Psychotropic Drug Prescribing Trends in Bahrain: Implications for Sexual Functions. International Journal of Clinical Medicine, Vol. 03, Issue. 04, p. 276.
Apantaku-Olajide, Tunde Gibbons, Pat and Higgins, Agnes 2011. Drug-induced sexual dysfunction and mental health patients' attitude to psychotropic medications. Sexual and Relationship Therapy, Vol. 26, Issue. 2, p. 145.
Miwa, Yoshiji Nagase, Keiko Oyama, Nobuyuki Akino, Hironobu and Yokoyama, Osamu 2011. Effect of Corticotropin‐Releasing Factor Receptor Antagonist on Psychologically Suppressed Masculine Sexual Behavior in Rats. The Journal of Sexual Medicine, Vol. 8, Issue. 3, p. 688.
Serretti, A and Chiesa, A 2011. Sexual Side Effects of Pharmacological Treatment of Psychiatric Diseases. Clinical Pharmacology & Therapeutics, Vol. 89, Issue. 1, p. 142.
IsHak, Waguih William Bokarius, Anna Jeffrey, Jessica K. Davis, Michael C. and Bakhta, Yekaterina 2010. Disorders of Orgasm in Women: A Literature Review of Etiology and Current Treatments. The Journal of Sexual Medicine, Vol. 7, Issue. 10, p. 3254.
Bhuvaneswar, Chaya G. Baldessarini, Ross J. Harsh, Veronica L. and Alpert, Jonathan E. 2009. Adverse Endocrine and Metabolic Effects of Psychotropic Drugs. CNS Drugs, Vol. 23, Issue. 12, p. 1003.
Verhulst, Johan and Reynolds, Jonathan K. 2009. Sexual Pharmacology: Love Potions, Pills, and Poisons. Journal of Family Psychotherapy, Vol. 20, Issue. 4, p. 319.
Rees, Margaret 2009. Alternative treatments for the menopause. Best Practice & Research Clinical Obstetrics & Gynaecology, Vol. 23, Issue. 1, p. 151.
Rossi, Alessandro Vita, Antonio Tiradritti, Paola and Romeo, Fabio 2008. Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone. International Clinical Psychopharmacology, Vol. 23, Issue. 4, p. 216.
Robin, G. Marcelli, F. Mitchell, V. Marchetti, C. Lemaitre, L. Dewailly, D. Leroy-Billiard, M. and Rigot, J.-M. 2008. Pourquoi et comment réaliser un bilan d’hypospermie ?. Gynécologie Obstétrique & Fertilité, Vol. 36, Issue. 10, p. 1035.
Resnik, Andrew G. and Ithman, Muaid H. 2008. The Human Sexual Response Cycle: Psychotropic Side Effects and Treatment Strategies. Psychiatric Annals, Vol. 38, Issue. 4, p. 267.
Ersoy, Mehmet A Noyan, Aysin M and Elbi, Hayriye 2008. An Open-Label Long-Term Naturalistic Study of Mirtazapine Treatment for Depression in Cancer Patients. Clinical Drug Investigation, Vol. 28, Issue. 2, p. 113.
Lavindran, Lakshmi N Eisfeld, Beata S. and Kennedy, Sidney H. 2008. Combining Mirtazapine and Duloxetine in Treatment-Resistant Depression Improves Outcomes and Sexual Function. Journal of Clinical Psychopharmacology, Vol. 28, Issue. 1, p. 107.
Psychotropic drugs are often associated with sexual dysfunction. The frequency of antidepressant-associated sexual dysfunction is greatly underestimated in clinical trials that rely on patient self-report of these adverse events. Direct inquiry reveals that delayed orgasm/ejaculation occurs in ≥50% and anorgasmia in at least one third of patients given selective serotonin reuptake inhibitors. Antidepressant-induced sexual dysfunction can be successfully managed. A different antidepressant without significant sexual effects, such as bupropion or mirtazapine, can often be substituted. Other strategies involve drug holidays or adjunctive therapy with drugs such as sildenafil. Dopamine antagonist antipsychotic drugs are most commonly associated with decreased libido. The newer atypical antipsychotics, with less effect on dopamine, are less commonly associated with sexual dysfunction. Sexual dysfunction is commonly reported with seizure disorders, and many anticonvulsant drugs affect levels of sex hormones. Because sexual dysfunction can be related to many factors, care must be taken to establish the patient's baseline sexual functioning before the initiation of psychotropic drug therapy and to rule out other etiologies before drugs are implicated as causative.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
Full text views reflects the number of PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.
* Views captured on Cambridge Core between September 2016 - 17th January 2018. This data will be updated every 24 hours.